Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Governance Functions to Accelerate Progress toward Universal Health Coverage (UHC) in the Asia-Pacific Region.

Yeoh EK, Johnston C, Chau PYK, Kiang N, Tin P, Tang J.

Health Syst Reform. 2019;5(1):48-58. doi: 10.1080/23288604.2018.1543521.

PMID:
30924745
2.

Multimorbidity in middle age predicts more subsequent hospital admissions than in older age: A nine-year retrospective cohort study of 121,188 discharged in-patients.

Lai FTT, Wong SYS, Yip BHK, Guthrie B, Mercer SW, Chung RY, Chung GKK, Chau PYK, Wong ELY, Woo J, Yeoh EK.

Eur J Intern Med. 2019 Mar;61:103-111. doi: 10.1016/j.ejim.2018.12.001. Epub 2018 Dec 20.

PMID:
30581041
3.

Management decision of hospital surge: assessing seasonal upsurge in inpatient medical bed occupancy rate among public acute hospitals in Hong Kong.

Poon CM, Wong ELY, Chau PYK, Yau SY, Yeoh EK.

QJM. 2019 Jan 1;112(1):11-16. doi: 10.1093/qjmed/hcy217.

PMID:
30295857
4.

Uncovering Hidden Topics in Hong Kong Clinical Research Through Hospital Authority Convention Publications.

Wong ZS, Chan WM, Wong EL, Chau PY, Tsui KL, Fung H.

Stud Health Technol Inform. 2017;245:624-628.

PMID:
29295171
5.

Care Toward the End of Life in Older Populations and Its Implementation Facilitators and Barriers: A Scoping Review.

Threapleton DE, Chung RY, Wong SYS, Wong ELY, Kiang N, Chau PYK, Woo J, Chung VCH, Yeoh EK.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1000-1009.e4. doi: 10.1016/j.jamda.2017.04.010. Epub 2017 Jun 13. Review.

6.

Knowledge, Attitudes, and Preferences of Advance Decisions, End-of-Life Care, and Place of Care and Death in Hong Kong. A Population-Based Telephone Survey of 1067 Adults.

Chung RY, Wong EL, Kiang N, Chau PY, Lau JYC, Wong SY, Yeoh EK, Woo JW.

J Am Med Dir Assoc. 2017 Apr 1;18(4):367.e19-367.e27. doi: 10.1016/j.jamda.2016.12.066. Epub 2017 Feb 14.

PMID:
28214237
7.

How shall we examine and learn about public-private partnerships (PPPs) in the health sector? Realist evaluation of PPPs in Hong Kong.

Wong EL, Yeoh EK, Chau PY, Yam CH, Cheung AW, Fung H.

Soc Sci Med. 2015 Dec;147:261-9. doi: 10.1016/j.socscimed.2015.11.012. Epub 2015 Nov 11.

8.

Assessing spatial associations between thermal stress and mortality in Hong Kong: a small-area ecological study.

Thach TQ, Zheng Q, Lai PC, Wong PP, Chau PY, Jahn HJ, Plass D, Katzschner L, Kraemer A, Wong CM.

Sci Total Environ. 2015 Jan 1;502:666-72. doi: 10.1016/j.scitotenv.2014.09.057. Epub 2014 Oct 10.

PMID:
25305328
9.

Excess winter mortality and cold temperatures in a subtropical city, Guangzhou, China.

Ou CQ, Song YF, Yang J, Chau PY, Yang L, Chen PY, Wong CM.

PLoS One. 2013 Oct 8;8(10):e77150. doi: 10.1371/journal.pone.0077150. eCollection 2013.

10.

Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost.

Plass D, Chau PY, Thach TQ, Jahn HJ, Lai PC, Wong CM, Kraemer A.

BMC Public Health. 2013 Sep 18;13:863. doi: 10.1186/1471-2458-13-863.

11.

Predictors and consequences of in-hospital formula supplementation for healthy breastfeeding newborns.

Parry JE, Ip DK, Chau PY, Wu KM, Tarrant M.

J Hum Lact. 2013 Nov;29(4):527-36. doi: 10.1177/0890334412474719. Epub 2013 Feb 25.

PMID:
23439865
12.

How to determine life expectancy change of air pollution mortality: a time series study.

Rabl A, Thach TQ, Chau PY, Wong CM.

Environ Health. 2011 Mar 31;10:25. doi: 10.1186/1476-069X-10-25.

13.

Part 5. Public health and air pollution in Asia (PAPA): a combined analysis of four studies of air pollution and mortality.

Wong CM, Vichit-Vadakan N, Vajanapoom N, Ostro B, Thach TQ, Chau PY, Chan EK, Chung RY, Ou CQ, Yang L, Peiris JS, Thomas GN, Lam TH, Wong TW, Hedley AJ, Kan H, Chen B, Zhao N, London SJ, Song G, Chen G, Zhang Y, Jiang L, Qian Z, He Q, Lin HM, Kong L, Zhou D, Liang S, Zhu Z, Liao D, Liu W, Bentley CM, Dan J, Wang B, Yang N, Xu S, Gong J, Wei H, Sun H, Qin Z; HEI Health Review Committee.

Res Rep Health Eff Inst. 2010 Nov;(154):377-418.

PMID:
21446215
14.

Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong.

Wong CM, Thach TQ, Chau PY, Chan EK, Chung RY, Ou CQ, Yang L, Peiris JS, Thomas GN, Lam TH, Wong TW, Hedley AJ; HEI Health Review Committee.

Res Rep Health Eff Inst. 2010 Nov;(154):283-362.

PMID:
21446214
15.

A review of effects of particulate matter-associated nickel and vanadium species on cardiovascular and respiratory systems.

Zhang Z, Chau PY, Lai HK, Wong CM.

Int J Environ Health Res. 2009 Jun;19(3):175-85. doi: 10.1080/09603120802460392. Review.

PMID:
20183191
16.

Seasonal effects of influenza on mortality in a subtropical city.

Yang L, Wong CM, Chan KP, Chau PY, Ou CQ, Chan KH, Peiris JS.

BMC Infect Dis. 2009 Aug 22;9:133. doi: 10.1186/1471-2334-9-133.

17.

Modification by influenza on health effects of air pollution in Hong Kong.

Wong CM, Yang L, Thach TQ, Chau PY, Chan KP, Thomas GN, Lam TH, Wong TW, Hedley AJ, Peiris JS.

Environ Health Perspect. 2009 Feb;117(2):248-53. doi: 10.1289/ehp.11605. Epub 2008 Oct 3.

18.

p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3.

Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT.

Mol Cancer Ther. 2007 Mar;6(3):1054-61.

19.

Genomic instability in laminopathy-based premature aging.

Liu B, Wang J, Chan KM, Tjia WM, Deng W, Guan X, Huang JD, Li KM, Chau PY, Chen DJ, Pei D, Pendas AM, Cadiñanos J, López-Otín C, Tse HF, Hutchison C, Chen J, Cao Y, Cheah KS, Tryggvason K, Zhou Z.

Nat Med. 2005 Jul;11(7):780-5. Epub 2005 Jun 26.

PMID:
15980864
20.

Activity of five fluoroquinolones against 71 isolates of Burkholderia pseudomallei.

Ho PL, Cheung TK, Kinoshita R, Tse CW, Yuen KY, Chau PY.

J Antimicrob Chemother. 2002 Jun;49(6):1042-4. No abstract available.

PMID:
12039903
21.

Cloning and expression of class A beta-lactamase gene blaA(BPS) in Burkholderia pseudomallei.

Cheung TK, Ho PL, Woo PC, Yuen KY, Chau PY.

Antimicrob Agents Chemother. 2002 Apr;46(4):1132-5.

22.

A tale of two cities: effects of air pollution on hospital admissions in Hong Kong and London compared.

Wong CM, Atkinson RW, Anderson HR, Hedley AJ, Ma S, Chau PY, Lam TH.

Environ Health Perspect. 2002 Jan;110(1):67-77.

23.
24.

beta-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like beta-lactamase, OXA-30.

Siu LK, Lo JY, Yuen KY, Chau PY, Ng MH, Ho PL.

Antimicrob Agents Chemother. 2000 Aug;44(8):2034-8.

25.

A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.

Cheng IK, Fang GX, Chau PY, Chan TM, Tong KL, Wong AK, Li CS, Lo WK, Cheung KO, Kumana CR.

Perit Dial Int. 1998 Jul-Aug;18(4):371-5.

PMID:
10505557
26.
27.

Physician acceptance of telemedicine technology: an empirical investigation.

Hu PJ, Chau PY.

Top Health Inf Manage. 1999 May;19(4):20-35.

PMID:
10387653
30.

A survey of physicians' acceptance of telemedicine.

Sheng OR, Hu PJ, Chau PY, Hjelm NM, Tam KY, Wei CP, Tse J.

J Telemed Telecare. 1998;4 Suppl 1:100-2.

PMID:
9640755
31.

Inpatient emergencies encountered by an infectious disease consultative service.

Luk WK, Wong SS, Yuen KY, Ho PL, Woo PC, Lee R, Peiris JS, Chau PY.

Clin Infect Dis. 1998 Mar;26(3):695-701.

PMID:
9524847
32.

Emerging pathogens: the Hong Kong experience.

Siau H, Yuen KY, Peiris JS, Wong SS, Ho PL, Cao L, Yam WC, Shortridge KF, Chau PY, Im SW, Ng MH.

Chin Med J (Engl). 1997 Jul;110(7):560-6. Review. No abstract available.

PMID:
9594216
33.

Transferable hyperproduction of TEM-1 beta-lactamase in Shigella flexneri due to a point mutation in the pribnow box.

Siu LK, Ho PL, Yuen KY, Wong SS, Chau PY.

Antimicrob Agents Chemother. 1997 Feb;41(2):468-70.

35.

Pulmonary melioidosis.

Ip M, Osterberg LG, Chau PY, Raffin TA.

Chest. 1995 Nov;108(5):1420-4. Review.

PMID:
7587451
36.

IS6110 based amplityping assay and RFLP fingerprinting of clinical isolates of Mycobacterium tuberculosis.

Yuen KY, Chan CM, Chan KS, Yam WC, Ho PL, Chau PY.

J Clin Pathol. 1995 Oct;48(10):924-8.

37.

Bacteriology of chronic suppurative otitis media: ofloxacin susceptibility.

Yuen AP, Chau PY, Wei WI.

J Otolaryngol. 1995 Jun;24(3):206-8.

PMID:
7674449
38.

Changing epidemiology of human salmonellosis in Hong Kong, 1982-93.

Wong SS, Yuen KY, Yam WC, Lee TY, Chau PY.

Epidemiol Infect. 1994 Dec;113(3):425-34.

39.

Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study.

Yuen PW, Lau SK, Chau PY, Hui Y, Wong SF, Wong S, Wei WI.

Am J Otol. 1994 Sep;15(5):670-3.

PMID:
8572070
40.

Serodiagnosis of Penicillium marneffei infection.

Yuen KY, Wong SS, Tsang DN, Chau PY.

Lancet. 1994 Aug 13;344(8920):444-5.

PMID:
7914566
41.

Antibiotic Guidelines.

Kumana CR, Chau PY, French G.

J R Coll Physicians Lond. 1993 Apr;27(2):199-200. No abstract available.

42.

Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis.

Yuen KY, Chan KS, Chan CM, Ho BS, Dai LK, Chau PY, Ng MH.

J Clin Pathol. 1993 Apr;46(4):318-22.

43.

Single-dose pharmacokinetics of intraperitoneal ofloxacin in patients on continuous ambulatory peritoneal dialysis.

Cheng IK, Chau PY, Kumana CR, Chan CY, Kou M, Siu LK.

Perit Dial Int. 1993;13 Suppl 2:S383-5.

PMID:
8399617
44.
46.

Characterization and application of a murine monoclonal antibody that reacts specifically with the serogroup D1 Salmonella.

Lu GZ, Tsang RS, Chau PY, Choi D, Law D, Ng MH.

FEMS Microbiol Lett. 1991 May 15;64(2-3):135-40.

PMID:
1884973
47.

Streptococcus zooepidemicus (Lancefield group C) septicaemia in Hong Kong.

Yuen KY, Seto WH, Choi CH, Ng W, Ho SW, Chau PY.

J Infect. 1990 Nov;21(3):241-50. Review.

PMID:
2273271
48.

In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis.

Yew WW, Kwan SY, Ma WK, Khin MA, Chau PY.

J Antimicrob Chemother. 1990 Aug;26(2):227-36.

PMID:
2120177
49.

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.

Liang R, Yung R, Chiu E, Chau PY, Chan TK, Lam WK, Todd D.

Antimicrob Agents Chemother. 1990 Jul;34(7):1336-41.

50.

Multi-resistant Streptococcus pneumoniae in Hong Kong.

Yuen KY, Seto WH, Hui WT, Chau PY.

J Antimicrob Chemother. 1990 Apr;25(4):721-3. No abstract available.

PMID:
2351638

Supplemental Content

Support Center